APH-0912

N/A

Report date: 2022/05/10 11:20:56

Base Information

Drug NameAPH-0912
Drug Alias NameAPH0912
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionMitosis inhibitorsTubulin polymerisation promotersTubulin inhibitors
TargetsTubulin
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAphios Corporation
China Registration ClassN/A

Develop Information

Active CompaniesAphios Corporation
Inactive CompaniesN/A
Active IndicationsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A